IN2013MU02442A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02442A
IN2013MU02442A IN2442MU2013A IN2013MU02442A IN 2013MU02442 A IN2013MU02442 A IN 2013MU02442A IN 2442MU2013 A IN2442MU2013 A IN 2442MU2013A IN 2013MU02442 A IN2013MU02442 A IN 2013MU02442A
Authority
IN
India
Prior art keywords
formula
compounds
present
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Jitendra D Patel
Prakash Davadra
Snehal Patel
Sheikh Shafiq
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN2442MU2013 priority Critical patent/IN2013MU02442A/en
Publication of IN2013MU02442A publication Critical patent/IN2013MU02442A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2442MU2013 2013-07-22 2013-07-22 IN2013MU02442A (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2442MU2013 IN2013MU02442A (en:Method) 2013-07-22 2013-07-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2442MU2013 IN2013MU02442A (en:Method) 2013-07-22 2013-07-22

Publications (1)

Publication Number Publication Date
IN2013MU02442A true IN2013MU02442A (en:Method) 2015-06-19

Family

ID=54396653

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2442MU2013 IN2013MU02442A (en:Method) 2013-07-22 2013-07-22

Country Status (1)

Country Link
IN (1) IN2013MU02442A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165782A1 (en) * 2019-02-13 2020-08-20 Cadila Healthcare Limited Treatment for polycystic ovarian syndrome (pcos)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165782A1 (en) * 2019-02-13 2020-08-20 Cadila Healthcare Limited Treatment for polycystic ovarian syndrome (pcos)

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
NZ716840A (en) Combination formulation of two antiviral compounds
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
PH12016500467A1 (en) Aminoheteroarlyl benzamides as kinase inhibitors
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2011010311A (es) Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas.
MY187718A (en) Pharmaceutical formulations
MX364400B (es) Compuestos de tetraciclina.
PH12016500577A1 (en) Piperazine derivatives and the use thereof as medicament
PH12016500461A1 (en) Polyethylene glycol-containing composition
MX2016001422A (es) Composicion farmaceutica de fingolimod.
WO2014166836A8 (en) Growth hormone compound formulation
WO2015002755A3 (en) Compounds for the treatment of malaria
MY181682A (en) Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it
IN2013MU02442A (en:Method)
PH12015502703A1 (en) Pharmaceutical compositions
MX358797B (es) Formulacion de aroma y fragancia (vi).
SA112330437B1 (ar) تركيبات دوائية محتوية على عامل منوم او مخدر وطريقة تحضيرها